INS and metabolic dysfunction-associated steatohepatitis: RNA sequencing has demonstrated overall downregulation of insulin signaling genes in the liver of obese individuals with NAFLD and non-alcoholic steatohepatitis (NASH) liver samples compared with lean and obese controls without steatosis [43].